A detailed history of Deka Bank Deutsche Girozentrale transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 7,142 shares of CRL stock, worth $1.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,142
Previous 7,906 9.66%
Holding current value
$1.42 Million
Previous $1.64 Million 13.96%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$187.96 - $245.29 $143,601 - $187,401
-764 Reduced 9.66%
7,142 $1.41 Million
Q2 2024

Aug 08, 2024

BUY
$206.39 - $268.73 $175,431 - $228,420
850 Added 12.05%
7,906 $1.64 Million
Q1 2024

Apr 24, 2024

SELL
$203.52 - $273.43 $1.43 Million - $1.92 Million
-7,038 Reduced 49.94%
7,056 $1.89 Million
Q4 2023

Jan 24, 2024

BUY
$164.52 - $238.84 $1.15 Million - $1.67 Million
6,997 Added 98.59%
14,094 $3.33 Million
Q3 2023

Nov 13, 2023

SELL
$194.44 - $217.61 $118,802 - $132,959
-611 Reduced 7.93%
7,097 $1.38 Million
Q2 2023

Jul 25, 2023

SELL
$183.71 - $210.25 $2.83 Million - $3.24 Million
-15,424 Reduced 66.68%
7,708 $1.61 Million
Q1 2023

Apr 24, 2023

SELL
$191.89 - $259.92 $1.18 Million - $1.6 Million
-6,171 Reduced 21.06%
23,132 $4.53 Million
Q4 2022

Feb 01, 2023

SELL
$197.11 - $250.07 $19,711 - $25,007
-100 Reduced 0.34%
29,303 $6.49 Million
Q3 2022

Nov 02, 2022

SELL
$182.44 - $250.54 $814,047 - $1.12 Million
-4,462 Reduced 13.18%
29,403 $5.53 Million
Q2 2022

Aug 03, 2022

BUY
$204.13 - $302.4 $3.87 Million - $5.73 Million
18,945 Added 126.98%
33,865 $7.33 Million
Q1 2022

Apr 28, 2022

BUY
$255.51 - $362.11 $169,403 - $240,078
663 Added 4.65%
14,920 $4.34 Million
Q4 2021

Feb 02, 2022

BUY
$351.38 - $448.68 $106,819 - $136,398
304 Added 2.18%
14,257 $5.31 Million
Q3 2021

Oct 22, 2021

BUY
$372.64 - $458.3 $2.8 Million - $3.45 Million
7,518 Added 116.83%
13,953 $5.85 Million
Q2 2021

Aug 05, 2021

BUY
$294.17 - $371.65 $1.45 Million - $1.83 Million
4,935 Added 329.0%
6,435 $2.37 Million
Q4 2020

Mar 12, 2021

BUY
$222.0 - $252.62 $333,000 - $378,930
1,500 New
1,500 $373,000
Q4 2019

Feb 04, 2020

SELL
$126.05 - $152.76 $84,201 - $102,043
-668 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$125.07 - $143.67 $81,170 - $93,241
-649 Reduced 49.28%
668 $89,000
Q2 2019

Aug 01, 2019

SELL
$123.4 - $148.55 $29.7 Million - $35.7 Million
-240,279 Reduced 99.45%
1,317 $185,000
Q1 2019

May 10, 2019

BUY
$104.82 - $146.73 $25.2 Million - $35.3 Million
240,279 Added 18244.42%
241,596 $29.4 Million
Q4 2018

Feb 12, 2019

SELL
$105.09 - $137.23 $25.3 Million - $33 Million
-240,279 Reduced 99.45%
1,317 $145,000
Q2 2018

Aug 14, 2018

BUY
$102.37 - $117.25 $1 Million - $1.15 Million
9,788 Added 4.22%
241,596 $26.9 Million
Q1 2018

May 03, 2018

BUY
$98.19 - $115.2 $22.8 Million - $26.7 Million
231,808 New
231,808 $24.6 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.